Reports for AVALIDE
Brand name
AVALIDE
Company Name
SANOFI-AVENTIS CANADA INC
|
Drug Identification Number
02241819 |
Ingredients
HYDROCHLOROTHIAZIDE IRBESARTAN |
Ingredient Strength
12.5 MG 300 MG |
ATC Code
C09DAC09DA |
ATC Descriptor
ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Status
MARKETED
|
Shortage reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
AVALIDE | Bottle of 90 tablets | Avoided shortage | 2022-04-14 | 2022-08-11 | 158890 |
AVALIDE | 90 | Resolved | 2019-02-08 | 2019-03-02 | 75166 |
AVALIDE | 90 | Resolved | 2019-05-08 | 2019-05-10 | 83440 |
AVALIDE | 90 | Resolved | 2019-07-16 | 2020-01-24 | 89482 |
AVALIDE | Bottle of 90 tablets | Resolved | 2022-08-11 | 2022-08-11 | 166530 |
Showing 1 to 5 of 5
Discontinuation reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0